CardieX subsidiary CONNEQT is debuting a new blood pressure monitor at the 2023 Consumer Electronics Show in Las Vegas Jan. 5-8.
The CONNEQT Pulse uses advanced arterial health technology to provide medical-grade heart health metrics from home.
The device can send data to a user’s physician to allow remote patient monitoring. It’s the world’s first vascular biometric health monitor and is specifically designed to meet home health, remote patient monitoring and decentralized clinical trial market needs.
The device incorporates SphygmoCor vascular bio sensing technology to provide medical-grade information about vascular health. It uses biometric sensors to collect meaningful digital vascular biomarkers, measuring multiple key heart health metrics including central blood pressure, brachial blood pressure, augmentation pressure, subendocardial viability ration and central pulse pressure. It also measures heart rate and reference age.
The device can be used to alert doctors to early warning signs of subclinical cardiovascular disease.
The device is awaiting final FDA clearance.
CardieX specializes in the development of biomarkers and digital solutions for large scale vascular health disorders.